Main Responsibilities
- Patient Advocacy Collaborations: Lead development/oversight of local Patient Advocacy Group (PAG) partnerships aligned with global R&D strategy across therapeutic areas, ensuring mutual benefit and positive customer experience.
- Clinical Trial Acceleration: Establish opportunities with Clinical Study Unit (CSU) colleagues to accelerate trials via Patient Experience Data (PED), optimized study design, and improved recruitment timelines.
- Data & Evidence Integration: Conduct patient data/Patient Disease Strategy (PDS) gap analysis; integrate local Real-World Evidence (RWE); ensure TVP/TPP/iEGP reflect local patient priorities.
- Digital & Innovation Leadership: Use digital tools and data opportunities within PAGs to drive efficiencies, accelerate deliverables, and identify patient-centric trial innovations.
- Cross-Functional Collaboration: Partner with Public Affairs, Medical Affairs, HVT, COA, and Ethics/Business Integrity to align strategies, stay current on regulations, and deliver publications/webinars.
- Local Insights & Outcomes: Translate local patient insights into endpoint/outcome measurement selection; main point of contact for meaningful country-specific data.
- Ecosystem Leadership: Lead evolving Integrated Patient Engagement (IPE) objectives; participate in external initiatives (PFDD, IMI, TransCelerate, PALADIN).
Basic Qualifications
- PharmD or equivalent advanced degree.
- Relevant education/experience in patient-focused drug development (clinical operations a plus); min 2 years in patient centricity, public affairs, or advocacy organization (preferable).
- At least 2 yearsβ pharma industry work/training experience.
- Deep knowledge of the North American healthcare system.
Preferred Qualifications / Skills
- Proven team leadership: collaboration, portfolio planning, communication, critical thinking/problem solving, training, multitasking, change management.
- Proficiency with Office tools; public speaking; affinity for AI solutions.
- Ability to implement innovations requiring significant stakeholder influence/management.
- Flexibility to accommodate working hours beyond 9β5.
- Strong local knowledge of pharma, patient advocacy, and regional healthcare systems.
Benefits
- Health and wellbeing benefits, including at least 14 weeksβ gender-neutral parental leave.